Professional
Added to YB: 2025-06-27
Pitch date: 2025-06-24
NUVB [neutral]
Nuvation Bio Inc.
+242.86%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment.
Market Cap
$2.2B
Pitch Price
$2.03
Price Target
7.50 (+16%)
Dividend
N/A
EV/EBITDA
-14.54
P/E
-14.18
EV/Sales
11.41
Sector
Pharmaceuticals
Category
special_situation
Show full summary:
NUVB: Heavy Insider Buying and Street Targets Signal Major Rebound Potential
$NUVB (quick pitch): Insiders making BIG open market purchases. Stock price melting with cash. AnHeart acquisition last year drove large price reaction. Revenue coming soon. Sell-side increasing price target with +300% upside potential.
Read full article (1 min)